Seon Kyeong Park

Seon Kyeong Park

Auto-generated profile, based on publicly available information

Seon Kyeong Park

Gyeonam Regional Center for Disease Control and Prevention, Korea Disease Control and Prevention Agency, Busan, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJu Hee Lee
Ju Hee Lee
JHJi Hae Hwang
Ji Hae Hwang
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
KLKil Hun Lee
Kil Hun Lee
YPYoung-Joon Park
Young-Joon Park
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SPSeon Kyeong Park
Seon Kyeong Park
YCYoung June Choe
Young June Choe
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
SLSang-Won Lee
Sang-Won Lee
YPYoung-Joon Park
Young-Joon Park
Park SK, et al. J Korean Med Sci. 2023 Apr;38(19):e143. https://doi.org/10.3346/jkms.2023.38.e143

30 June 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
JHJi Hae Hwang
Ji Hae Hwang
JLJu Hee Lee
Ju Hee Lee
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
KLKil Hun Lee
Kil Hun Lee
YPYoung-Joon Park
Young-Joon Park
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.

31 October 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
MLMINJEI LEE
MINJEI LEE
MHMyung-Jae Hwang
Myung-Jae Hwang
DKDong Seob Kim
Dong Seob Kim
SPSeon Kyeong Park
Seon Kyeong Park
JCJihyun Choi
Jihyun Choi
SLSang Eun Lee
Sang Eun Lee
Objectives: We evaluated the effectiveness of coronavirus disease 2019 vaccination in high-risk facilities in the Republic of Korea during the period when the highly transmissible Delta variant was prevalent. Additionally, we aimed to explore any disparities in vaccine effectiveness (VE) across various types of institutions, specifically distinguishing between non-medical and medical establishments. Methods: We examined 8 outbreak clusters covering 243 cases and 895 contacts from 8 high-risk facilities divided into 2 groups: group A (4 non-medical institutions) and group B (4 medical institutions). These clusters were observed from July 27, 2021 to October 16, 2021 for the attack rate (AR) and VE with respect to disease severity. A generalized linear model with a binomial distribution was used to determine the odds ratio (OR) for disease severity and death. Results: AR was notably lower in group B (medical institutions). Furthermore, VE analysis revealed that group A exhibited higher effectivity for disease severity and death than group B. The OR for disease severity was 0.24 (95% confidence interval [CI], 0.03–2.16) for group A and 0.27 (95% CI, 0.12–0.64) for group B, with the OR for death at 0.12 (95% CI, 0.01–1.32) in group A and 0.34 (95% CI, 0.14–0.87) in group B. Conclusion: Although VE may vary across institutions, our findings underscore the importance of implementing vaccinations in high-risk facilities. Customized vaccination programs, tailored response plans, and competent management personnel are essential for effectively addressing and mitigating public health challenges.